The Secreted Metabolite Isopentenyladenine from Faecalibacterium prausnitzii Is Anti-inflammatory with Barrier-Protective Properties
L. Yao, Angelo Solania, Anny‐Claude Luissint, Aaron T. Balana et autres
2 citationsACS Infectious Diseases
James Kuo
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
50Publications signalées
5720Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesMRI in cancer diagnosisCancer Genomics and Diagnostics
Publications récentes
The Secreted Metabolite Isopentenyladenine from Faecalibacterium prausnitzii Mitigates Gut Inflammation
Lina Yao, Angelo Solania, Anny‐Claude Luissint, Aaron T. Balana et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Toxigenic Clostridium perfringens Isolated from At-Risk Paediatric Inflammatory Bowel Disease Patients
James Kuo, Jasmina Uzunović, Amanda Jacobson, Michelle Dourado et autres
12 citationsJournal of Crohn s and Colitis
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
Daphne Day, John Park, Jermaine Coward, Ben Markman et autres
7 citationsBritish Journal of Cancer
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
Sunit Sarkar, Ben Tran, Lisa G. Horvath, Michael Lam et autres
0 citationsCancer Chemotherapy and Pharmacology
KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong, Marwan Fakih, John H. Strickler, Jayesh Desai et autres
1738 citationsNew England Journal of Medicine
CodeBreak 100: Phase I study of AMG 510, a novel KRASG12C inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).
David S. Hong, James Kuo, Adrian G. Sacher, Fabrice Barlési et autres
25 citationsJournal of Clinical Oncology
A Randomized Trial of the Electronic Lung Cancer Symptom Scale for Quality-of-Life Assessment in Patients with Advanced Non-small-Cell Lung Cancer
James Kuo, Donna M. Graham, Alexandra Salvarrey, F. Kassam et autres
14 citationsCurrent Oncology
Complete Reconstitution and Deorphanization of the 3 MDa Nocardiosis-Associated Polyketide Synthase
Kai P. Yuet, Corey W. Liu, Stephen R. Lynch, James Kuo et autres
38 citationsJournal of the American Chemical Society
Complete Reconstitution and Deorphanization of the 3 MDa NOCAP (NOCardiosis-Associated Polyketide) Synthase
Kai P. Yuet, Corey W. Liu, Stephen R. Lynch, James Kuo et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Combined Cancer Patient–Reported Symptom and Health Utility Tool for Routine Clinical Implementation: A Real-World Comparison of the ESAS and EQ-5D in Multiple Cancer Sites
Mor Moskovitz, Kevin Jao, Jiandong Su, M. Catherine Brown et autres
8 citationsCurrent Oncology
P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer
Ramaswamy Govindan, Marwan Fakih, T.J. Price, Gerald S. Falchook et autres
3 citationsJournal of Thoracic Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.